MOLECULAR RESPONSE
Molecular Response is an oncology research platform that comprises the largest collection of viable tumor specimens.
MOLECULAR RESPONSE
Industry:
Health Care Medical
Address:
San Diego, California, United States
Country:
United States
Status:
Active
Similar Organizations
Brevard Eye Center
Brevard Eye Center is an eye care healthcare centre that deals with the protection and care of eyes.
iCoreConnect
iCoreConnect is an online platform that provides secure communications solutions for the healthcare community.
NEXT Molecular Analytics
NEXT Molecular is a contract research organization that provides integrated research and development sciences and clinical testing services.
More informations about "Molecular Response"
BioDuro Completes Acquisition of Molecular Response to …
San Diego, March 5, 2018 – PR Newswire – BioDuro LLC, a leading global life sciences contract research and development organization, announced today the acquisition of Molecular Response LLC and its world-class translational oncology research platform, including its biobank of …See details»
Molecular Response - Crunchbase Company Profile & Funding
Organization. Molecular Response . Connect to CRM . Save . Summary. People. Signals & News. Similar Companies. About. Molecular Response is an oncology research platform that …See details»
BioDuro Acquires Molecular Response - bridgewestgroup.com
BioDuro acquires Molecular Response and its world-class translational oncology research platform, including its biobank of >100,000 viable tumor specimens. ... BioDuro is a leading, …See details»
BioDuro Acquires Molecular Response Cancer Biobank And …
Mar 5, 2018 BioDuro LLC is a global life sciences contract research and development organization (CRO). The company has acquired Molecular Response LLC and its extensive …See details»
Molecular Response - Products, Competitors, Financials, …
Molecular Response. Frequently Asked Questions (FAQ). When was Molecular Response founded? Molecular Response was founded in 2010. Where is Molecular Response's …See details»
Chronic Myeloid Leukemia (CML) | Treatment Response …
Achieving a deep molecular response is a sign of disease remission. Patients who achieve and then sustain a deep molecular response for a significant period of time may be considered candidates for discontinuing TKI therapy under …See details»
Why is it critical to achieve a deep molecular response …
This response was subsequently described as a ‘safe haven’ in which the risk of loss of response is low. 3 The rate of MMR is now a primary or secondary outcome measure in CML clinical trials 4, 5 and is measured on an …See details»
Molecular response in CML: where is the bar? Free
Jul 24, 2014 For almost 10 years, the main goal of the treatment of CML with tyrosine kinase inhibitors (TKIs) has been the achievement of the so-called “major molecular response” (MMR; BCR-ABL1 ≤ 0.1% on the International Scale) 2 …See details»
Standardized definitions of molecular response in chronic myeloid ...
Apr 16, 2012 The International Randomized Study of Interferon and STI571 (IRIS) demonstrated long-term cytogenetic responses in patients with chronic-phase chronic myeloid leukemia …See details»
Molecular response and quality of life in chronic …
Feb 16, 2021 Molecular response (≤0.1% BCR-ABL1%IS) is achieved in 80–90% of patients and 30–50% of them obtain deep molecular response (DMR) (≥MR 4.0 ≤0.01% BCR-ABL1%IS or 10.000 copies of transcript as minimum …See details»
Achieving deeper molecular response is associated …
Patients who achieved complete molecular response had better event-free and failure-free survivals than those with complete cytogenetic response irrespective of major molecular response status (95.2% vs. 64.7% vs. 27.7%, P=0.00124; …See details»
Tumour and microenvironment crosstalk in NSCLC progression …
3 days ago An important yet underexplored aspect of the NSCLC TME is its spatial heterogeneity, that is, the non-uniform distribution and organization of cellular and molecular …See details»
Death-ision: the link between cellular resilience and cancer …
3 days ago In contrast, immunogenic cell death (ICD), a form of RCD which results in the release of damage-associated molecular patterns (DAMPs), promotes dendritic cell maturation …See details»
BioDuro Completes Acquisition of Molecular Response to …
SAN DIEGO, March 5, 2018 /PRNewswire/ -- BioDuro LLC, a leading global life sciences contract research and development organization, announced today the acquisition of Molecular …See details»
Molecular response in newly diagnosed chronic-phase chronic …
Chronologically, the first milestone of molecular response is a BCR::ABL1 on the International Scale (IS) level of ≤10% after 3 to 6 months of therapy, denoted as early molecular response …See details»
BioDuro Completes Acquisition of Molecular Response to
Mar 5, 2018 Company adds 100,000 tumors to portfolio; enables broad access to proven technology platform.See details»
The 2020 revision of the guidelines for the management of ...
Molecular response is not required for assignment as complete response or partial response. Molecular response evaluation requires analysis in peripheral blood granulocytes. Complete …See details»
Molecular Response - Crunchbase Company Profile & Funding
Organization. Molecular Response . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. Molecular Response provides clinical support …See details»
Analyzing molecular response in chronic myeloid leukemia clinical ...
Oct 24, 2014 Major molecular response (MMR) was defined early on as a ratio of ≤0.1% BCR-ABL1 on the IS scale, a definition that still stands today However, the concept of complete MR …See details»
Patient-specific molecular response dynamics can predict the ...
This method can predict a response by recursively partitioning data into two subgroups based on the predictor values. Results Patient-specific molecular response to IM therapy and …See details»